GT5150 Posted - 19 hours ago

$ACET

GT5150 Posted - 19 hours ago

$ACET This gap between $11 & $18 will be filled....are they always not? " they" say........

oneyd2go Posted - 20 hours ago

$ACET I guess the pre market was an omen of the days events and I guess nobody cares.

oneyd2go Posted - 1 day ago

$ACET and now were down, that's ok I was looking to add under $2.15, my avg is $2.19

oneyd2go Posted - 1 day ago

$ACET I guess the $2.37 I just saw in the premarket was a misprint. Waiting on news, then we rocket higher.

euu9 Posted - 1 day ago

$ACET I started buying it since last Friday. I will add a little everyday and hold for at least 3 to 5 years

Stock_Titan Posted - 1 week ago

$ACET Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference https://www.stocktitan.net/news/ACET/adicet-bio-to-participate-in-2024-canaccord-genuity-horizons-in-rfne051793kn.html

Doorkey Posted - 1 week ago

$ACET Added on watchlist.

batmanandrobinhood Posted - 2 weeks ago

$ACET waiting for this to go a little lower and I'll load up. This is a long term gold mine imo. 🙌

Hereinbama35 Posted - 2 weeks ago

$ACET Eight analyst buy ratings can’t be wrong! Am I right? Huh? 😁

oneyd2go Posted - 2 weeks ago

$ACET this shouldn't be affected like the pharmas but the sector could drag it down anyway.

Oversold_Gems Posted - 2 weeks ago

$ACET

Pepgiova Posted - 2 weeks ago

$ACET buying more today.

Stock_Titan Posted - 03/28/24

$ACET Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ACET/adicet-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-mgolqg3lbwyf.html

mscp Posted - 03/28/24

$ACET need some news. will send this on run

Oversold_Gems Posted - 03/25/24

$ACET

oneyd2go Posted - 03/25/24

$ACET momentum IS in our favor now, time to ride this until results are announced.

VvapWinner Posted - 03/23/24

$ACET

oneyd2go Posted - 03/22/24

$ACET momentum going again

Bobaloo66 Posted - 03/20/24

$ACET The shorts knocked this tight back from $2.20’s

oneyd2go Posted - 03/20/24

$ACET I'm seeing this up .11 premarket, anyone else?

Bobaloo66 Posted - 03/20/24

$ACET ….and back to our regular scheduled program

johnconner1 Posted - 03/19/24

$ACET c h breakdown was discouraging

theflynews Posted - 03/19/24

Fly Intel: After-Hours Movers - $ACET - https://thefly.com/permalinks/entry.php/ACETid3884761

oneyd2go Posted - 03/19/24

$ACET hold for the next year

DonCorleone77 Posted - 03/19/24

$ACET 2 of 2 - Adicet Bio reports Q4 EPS (69c), consensus (69c) ....study of ADI-001 in relapsed or refractory non-Hodgkin's lymphoma. With the completion of the successful capital raise and other net proceeds from stock sales under the at-the-market program in January, extending our cash runway into the second half of 2026, we are well-positioned to continue clinical execution across our pipeline through multiple upcoming milestones." Cash and cash equivalents were $159.7 million as of December 31, 2023, compared to $257.7 million as of December 31, 2022. Subsequent to December 31, 2023, the Company received $91.8 million of net proceeds from an underwritten public offering and $19.3 million of net proceeds under its ATM program. The Company expects that its cash and cash equivalents as of December 31, 2023, together with the proceeds raised subsequent to year end, will be sufficient to fund its operating expenses into the second half of 2026.

DonCorleone77 Posted - 03/19/24

$ACET 1 of 2 - Adicet Bio reports Q4 EPS (69c), consensus (69c) "We are excited to explore the potential of our gamma delta T cell platform in autoimmune diseases following the FDA's IND clearance of ADI-001 in lupus nephritis," said Chen Schor, CEO. "We believe ADI-001 is ideally suited for the treatment of autoimmune diseases given its robust B-cell depletion consistent with other autologous CAR T therapies tested in autoimmune diseases, its tissue tropism potential in autoimmune diseases, and the safety and efficacy data observed in our Phase 1 study. In addition, ADI-001's off-the-shelf availability and safety profile has the potential to make cell therapy for autoimmune diseases available to patients in community setting. We look forward to initiating the Phase 1 study in lupus nephritis in the second quarter of 2024 and are on track to expand the program to additional autoimmune indications. In addition, we are continuing to enroll MCL patients in our ongoing Phase 1....

Stock_Titan Posted - 03/19/24

$ACET Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress https://www.stocktitan.net/news/ACET/adicet-reports-fourth-quarter-and-full-year-2023-financial-results-teamkuezjdvl.html

oneyd2go Posted - 4 weeks ago

$ACET Let’s hope something comes out of this Fireside chat, I mean they aren’t doing it to release bad news.

Ilygod Posted - 4 weeks ago

$ACET Let's see some of those 21% shorts get squeezed to $3.5